Defence Therapeutics CEO presents at World ADC conference on intracellular delivery in antibody-drug conjugates

• Defence Therapeutics will attend World ADC San Diego in San Diego, California, Oct. 12–15, 2026.
• CEO Amie Phinney is scheduled to present Oct. 14 at 12:30 p.m. in a session on intracellular delivery for ADCs.
• Senior Scientist Guillaume Lefrançois will present an Accum-related scientific poster Tuesday afternoon, Oct. 13.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Defence Therapeutics Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610010315NEWSFILECNPR____20261001_316757_1) on October 01, 2026, and is solely responsible for the information contained therein.